Since Lung Therapeutics was founded in 2013, it has participated in 7 rounds of funding. In total Lung Therapeutics has raised $67.3M. Lung Therapeutics' last funding round was on Mar 2022 for a total of $10.1M.
Lung Therapeutics has 5 investors, including Bios Partners, National Institutes of Health and U.S. Small Business Administration.. The latest investment occurred in Mar 2022.
